Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - chloropicrin - liquid - chloropicrin gas active 985.0 g/kg - mixed function pesticide - pre-planting soil treatment | rabbit burrow | soil heaps (under plastic or in drums) - bacteria | insect | nematode - soil borne plant parasitic | rabbit | soil borne fungi | weed seed | fat hen | prince of wales feather | weed seeds | winter grass

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

eastman chemical australia pty ltd - metham present as sodium salt - soluble concentrate - metham present as sodium salt carbamate-dithiocarbamate active 423.0 g/l - mixed function pesticide - bulk potting soil | field application to beds or rows | field application to total area | lawn | seedbed | tobacco - prior to so - fungal diseases - see label | nematode - soil borne plant parasitic | onion weed | symphylid | weed seed - see label | asphodel | club root of crucifers | fat hen | fusarium | garden centipedes | onion grass | phytophthora | prince of wales feather | pythium | rhizoctonia | sclerotinia | symphylans | verticillium | weed seeds | wild onion | winter grass

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

conquest crop protection pty ltd - dicamba as the sodium salt - water soluble granules - dicamba as the sodium salt benzoic acid-arylaliphatic active 700.0 g/kg - herbicide

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine accord is indicated for the treatment of patients with,? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), ,? chronic myelomonocytic leukemia (cmmol (10-29 percent marrow blasts without myeloproliferative disorder)), ,? acute myeloid leukemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who), ,in whom allogenic stem cell transplantation is not indicated.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - flecainide acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; maize starch - 1. supraventricular arrhythmias: a) due to pre-excitation syndromes, e.g. wolff-parkinson-white and lown-ganong-levine syndromes. b) due to dual av nodal pathways in patients with debilitating symptoms. c) paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms.,although flecainide may be effective in supraventricular arrhythmias in patients with structural heart disease, its use has been associated with life-threatening and occasionally fatal ventricular arrhythmias. in these patients, particularly in the presence of impaired left ventricular function, flecainide should be used with extreme caution, preferably after other antiarrhythmic drugs have been tried or considered inappropriate.,use of flecainide in chronic atrial fibrillation has not been adequately studied and is not recommended.,2. life threatening ventricular arrhythmias not controlled by other drugs.,flecainide sandoz tablets are used for continuous maintenance of normal rhythm following initial oral or intravenous therapy or conversion by other means.,prescribers should also consult the "precautions" section of this product information.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - flecainide acetate, quantity: 50 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; maize starch; microcrystalline cellulose; croscarmellose sodium; magnesium stearate - 1. supraventricular arrhythmias: a) due to pre-excitation syndromes, e.g. wolff-parkinson-white and lown-ganong-levine syndromes. b) due to dual av nodal pathways in patients with debilitating symptoms. c) paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms.,although flecainide may be effective in supraventricular arrhythmias in patients with structural heart disease, its use has been associated with life-threatening and occasionally fatal ventricular arrhythmias. in these patients, particularly in the presence of impaired left ventricular function, flecainide should be used with extreme caution, preferably after other antiarrhythmic drugs have been tried or considered inappropriate.,use of flecainide in chronic atrial fibrillation has not been adequately studied and is not recommended.,2. life threatening ventricular arrhythmias not controlled by other drugs.,flecainide sandoz tablets are used for continuous maintenance of normal rhythm following initial oral or intravenous therapy or conversion by other means.,prescribers should also consult the "precautions" section of this product information.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

clearpath orthocare australia pty ltd - 44738 - orthodontic appliance system, progressive - progressive dental aligners designed to influence the shape and/or function of the stomatognathic system by using a series of preformed teeth aligners/positioners, each worn in succession and changed every few weeks

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine is indicated for the treatment of patients with: ? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), ? chronic myelomonocytic leukemia [cmmol (10%-29% marrow blasts without myeloproliferative disorder)], ? acute myeloid leukemia (aml) with 20-30% blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine is indicated for the treatment of patients with: ? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), ? chronic myelomonocytic leukemia [cmmol (10%-29% marrow blasts without myeloproliferative disorder)], ? acute myeloid leukemia (aml) with 20-30% blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - metham present as sodium salt - soluble concentrate - metham present as sodium salt carbamate-dithiocarbamate active 423.0 g/l - mixed function pesticide - lawn | limited area | potting soil - floriculture & ornamental | seedbed | tobacco plant bed - club root of crucifers | fat hen | fungal diseases - see label | fusarium soil fungus | nematode - soil borne plant parasitic | onion weed | phytophthora soil fungus | prince of wales feather | pythium spp. | rhizoctonia | sclerotinia rot | symphylid | verticillium wilt | weed seed - see label | winter grass | amaranthus cruentus | amaranthus powellii | amaranthus viridis | annual blue grass | annual poa | asphodel | club root of crucifers | fat hen | fusarium | garden centipedes | goose grass | grease spot | onion grass | phytophthora | prince of wales feather | ptilotus exaltus | pythium | pythium blight | rhizoctonia | sclerotinia | sclerotinia flower blight | sclerotinia fungal disease | sclerotinia root rot | sclerotinia soil fungus | soil fungi | symphylans | verticillium | verticillium dahliae | verticillium soil fungus | weed seeds | white goosefoot | white mould | wild onion | wilt - sclerotinia | winter grass